Specific activation of glycolytic enzyme enolase 2 in BRAF V600E‐mutated colorectal cancer

The BRAF V600E mutation occurs in approximately 10% of patients with metastatic colorectal cancer (CRC) and constitutes a distinct subtype of the disease with extremely poor prognosis. To address this refractory disease, we investigated the unique metabolic gene profile of BRAF V600E‐mutated tumors...

Descripción completa

Detalles Bibliográficos
Autores principales: Yukimoto, Ryohei, Nishida, Naohiro, Hata, Tsuyoshi, Fujino, Shiki, Ogino, Takayuki, Miyoshi, Norikatsu, Takahashi, Hidekazu, Uemura, Mamoru, Satoh, Taroh, Hirofumi, Yamamoto, Mizushima, Tsunekazu, Doki, Yuichiro, Eguchi, Hidetoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253290/
https://www.ncbi.nlm.nih.gov/pubmed/33934428
http://dx.doi.org/10.1111/cas.14929

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253290/
https://www.ncbi.nlm.nih.gov/pubmed/33934428
http://dx.doi.org/10.1111/cas.14929

Ejemplares similares